T
Tempest Therapeutics, Inc. (TPST)
NCM – Real vaqt narxi. Valyuta: USD
1.21
+0.03 (2.54%)
Yopilishda: Aug 12, 2026, 4:00 PM EDT
1.23
+0.02 (1.65%)
Bozordan keyin: Aug 12, 2026, 4:47 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
1.21
+0.03 (2.54%)
Yopilishda: Aug 12, 2026, 4:00 PM EDT
1.23
+0.02 (1.65%)
Bozordan keyin: Aug 12, 2026, 4:47 PM EDT
Tempest Therapeutics, Inc. klinik bosqichdagi biotexnologiya kompaniyasi bo'lib, saratonni davolash uchun kichik molekulali dorilarni ishlab chiqadi. Uning asosiy mahsulot nomzodlari orasida Amezalpat, 2-bosqichli klinik sinovni tugatgan birinchi liniyali rezektsiya qilinmaydigan yoki metastatik gepatotsellyulyar karsinomani davolash uchun peroksizom proliferator bilan faollashtiriladigan retseptor alfa ning og'iz orqali qabul qilinadigan kichik molekulali selektiv antagonisti; va TPST-1495, prostaglandin E2 ning EP2 va EP4 retseptorlarining kichik molekulali er-xotin antagonisti, turli saratonlarni davolash uchun kiradi. Kompaniya Amezalpatni global birinchi liniyali randomizatsiyalangan tadqiqotga aylantirish bo'yicha F. Hoffmann-La Roche Ltd. bilan hamkorlik shartnomasiga ega; va TPST-4003 mahsuloti nomzodini ishlab chiqish uchun Heibei Senlang Biotechnology Co., Ltd. bilan mahsulotni ishlab chiqish va tadqiqotchi tomonidan boshlanadigan sinov hamkorlik shartnomasiga ega. Tempest Therapeutics, Inc. shtab-kvartirasi Kaliforniyaning Brisbane shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Andrew Fang Ph.D. | Head of Business Development |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-07-28 | 8-K | d105624d8k.htm |
| 2026-07-22 | 8-K | d107304d8k.htm |
| 2026-07-17 | DEF 14A | ny20077454x2_def14a.htm |
| 2026-07-07 | PRE 14A | ny20077454x1_pre14a.htm |
| 2026-06-26 | S-3 | d135184ds3.htm |
| 2026-06-23 | D | |
| 2026-06-23 | 8-K | d158247d8k.htm |
| 2026-06-08 | DEF 14A | ny20072803x2_def14a.htm |
| 2026-06-04 | 8-K | d91703d8k.htm |
| 2026-06-02 | 8-K | d105562d8k.htm |